Education > Article > Female EcologiX: Your New Clinical Tool

Female EcologiX: Your New Clinical Tool

Learn about your new clinical tool: Female EcologiX Vaginal Health & Microbiome Profile


Female EcologiX™ | Host-Microbiome Analysis

The vaginal microbiome is a key ecosystem, which is host to over 200 species of microorganisms. Unlike other microbiota sites, the vagina is extremely dynamic and is affected by numerous host factors including age, ethnic background, sexual intercourse, changes in hormone levels during pregnancy, menstruation and menopause, genital infections and personal hygiene.

Due to its extensive interaction and cross-talk with host immune responses, small fluctuations in the vaginal microbiota can impact vaginal health significantly. The disruption of homeostasis, termed dysbiosis, has been linked to a multitude of conditions, including bacterial vaginosis (BV), miscarriages, preterm delivery, pelvic inflammatory disease (PID) and increased risk of sexually transmitted infections (STIs).

Analysis and monitoring of the vaginal microbiota is therefore extremely important for health and can be used to inform treatment plans and lifestyle factors.

vaginal ecosystem
Figure 1: Dysbiosis in the vaginal microbiota. Disruption of vaginal Lactobacillus species may result in colonisation and overgrowth of strictly anaerobic bacteria including Prevotella bivia and Gardnerella. Overgrowth of strict anaerobes results in increased levels of pro-inflammatory cytokines, reduced production of lactic acid, reduced production of antimicrobial peptides and thus, pathogen colonisation and epithelial injury. Adapted from Aldunate et al (2015).
The Female EcologiX™ Profile

Methodology:
The profile uses two technologies: quantitative real-time PCR is (q-RT-PCR) is used to quantify the abundance of microbial genes. Enzyme-linked immunosorbent assays (ELISA) are used for the quantification of host proteins

For microbiota composition analysis, the technology detects:

  • Abundance of four key Lactobacillus species (markers for vaginal health)
  • Abundance of strictly anaerobic bacteria (associated with dysbiosis)
  • Abundance of enteric bacteria including Escherichia coli and Staphylococcus aureus (associated with aerobic vaginitis)
  • Abundance of BV-associated bacteria including Gardnerella, Prevotella and Megasphaeraspecies
For host biomarker analysis, the technology detects:
  • pH
  • IL-1β (pro-inflammatory cytokine)

Dependent on microbiota composition and host biomarkers, the profile will report three different states:

  • Healthy vaginal microbiota (homeostasis)
  • Vaginal dysbiosis (microbiota profile and/or host marker profile)

 


Materials & Support

Female EcologiX

Downloads:
Sample report
Interpretive guide
Clinical matrix
Clinical considerations (logged-in only)

Consultations:
We offer complimentary consults with our clinical education team. You can book these from your account dashboard.

 


Relevant Education
Female Ecology: The Menopausal Vagina

Strategies to question, support, and address vaginal health in menopause.
1 hour webinar
→ watch

Female Ecology Mastercourse

Master female ecology in clinical practice with our online 6-week course.
9 hours over 6 classes
→ watch

Related Articles


Bio.Clear, Bio.Me, Gastrointestinal, GI EcologiX™, Immunology & Inflammation, Microbiome
Optimising Your Immune System

To help optimise immunity, it is imperative that we nourish the immune system from the outside-in and inside-out with an emphasis on nurturing our relationship with the microbial colonies with ...

Diagnostics, GI EcologiX™, Microbiome
Gut Health and Microbiome Stool Test

The GI EcologiX profile is one of our 'hero' products. From day one, our aim was to produce a gut microbiome profile that represents the ultimate in science, clinical utility, ...

Gastrointestinal, GI EcologiX™, Microbiome
Gut Health and Microbiome Standalone Profiles

We hear you loud and clear – sometimes you want to check a particular marker, or set of markers, after your intervention to get an update on your patient’s clinical ...